News

27. 09.2017

SABRE trial published in JACC

Category: News

• #Publication

The SABRE (Sirolimus Angioplasty Balloon for Coronary In-Stent Restenosis) trial was a prospective, single-arm, feasibility study involving 9 European centers to evaluate the safety and effectiveness of the Virtue balloon for coronary ISR, and powered to demonstrate superiority over (historically documented) plain balloon angioplasty treatment.

Read more

05. 09.2017

genae Launches staicy

Category: News

• #Data
• #Clinical research
• #Press release
• #Electronic Data Capture
• #staicy

genae, a global service provider for the medical industries, today announced the launch of staicy, a data-driven health and research management platform.

Read more

27. 07.2017

genae appoints new board member

Category: News

genae announced today the appointment of Thomas De Kempeneer as a member of genae’s board of directors.

Read more

30. 05.2017

genae Invests in Meditrix

Category: News

• #Press release

genae, a global Contract Research Organization (CRO) and service provider for the medical industries, announced the closing of an investment in Meditrix. The clinical research group further obtained a call option to acquire all remaining shares of Meditrix.

Read more